Showing 1 - 10 of 1,230
Persistent link: https://www.econbiz.de/10010523456
Although diet structure and activity throughout the developing world have shifted drastically over the past several … effects, such as obesity, heart disease and cancer, of those shifts. Two questions specifically need to be addressed: a) Are …
Persistent link: https://www.econbiz.de/10012558404
of HIV/AIDS. It was developed in response to numerous requests for a simple forum to help countries share their practical …
Persistent link: https://www.econbiz.de/10012563807
The report discusses inter-related parts of blood transfusions systems, and presents an overview of the parts that need to be strengthened in Central Asia. Numerous parts are in serious need of organizational restructuring, new investment and increased budgetary support for operation and...
Persistent link: https://www.econbiz.de/10012553035
Tuberculosis (TB) and HIV/AIDS have a significant impact on the economy and society of Kazakhstan and a growing … the human capital development of the country. To face the challenge of the dual threat of HIV/AIDS and TB focused, highly … study addresses the overall performance of the tuberculosis, human immunodeficiency virus (HIV) and acquired immune …
Persistent link: https://www.econbiz.de/10012553494
The epidemic spread of HIV/AIDS has been ferocious, posing a great threat, not only to public health, but to social … sectors, and to development itself, while the fiscal cost of HIV/AIDS is significant as well. A set of effective prevention …
Persistent link: https://www.econbiz.de/10012554820
response to the HIV/AIDS epidemic was also assessed to develop recommendations for improving resource allocation and program …This synthesis paper describes the HIV epidemics in 15 West African countries - Benin, Burkina Faso, Cote d …
Persistent link: https://www.econbiz.de/10012557410
Persistent link: https://www.econbiz.de/10011393507
Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a share of Gross Domestic Product (GDP). Similarly, pharmaceutical expenditure in comparative perspective is not particularly high on a per capita basis or as a percentage of GDP....
Persistent link: https://www.econbiz.de/10012247334